Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
2.080
+0.080 (4.00%)
At close: Oct 5, 2026, 4:00 PM EDT
2.080
0.00 (0.00%)
After-hours: Oct 5, 2026, 5:32 PM EDT
Cabaletta Bio Market Cap
Cabaletta Bio has a market cap or net worth of $352.65 million as of October 5, 2026. Its market cap has increased by 58.02% in one year.
Market Cap
352.65M
Enterprise Value
153.27M
1-Year Change
58.02%
Ranking
Category
Stock Price
$2.08
ChartMarket Cap Chart
Since October 25, 2019, Cabaletta Bio's market cap has increased from $235.53M to $352.65M, an increase of 49.73%. That is a compound annual growth rate of 5.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2026 | 352.65M | 67.28% |
| Dec 31, 2025 | 210.82M | 90.01% |
| Dec 31, 2024 | 110.95M | -88.59% |
| Dec 29, 2023 | 972.68M | 260.85% |
| Dec 30, 2022 | 269.55M | 151.03% |
| Dec 31, 2021 | 107.38M | -64.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Inhibikase Therapeutics | 364.15M |
| C4 Therapeutics | 362.92M |
| Fennec Pharmaceuticals | 357.69M |
| Orchestra BioMed Holdings | 357.63M |
| Ocugen | 345.89M |
| Surrozen | 344.61M |
| Artiva Biotherapeutics | 333.92M |
| Scribe Therapeutics | 317.86M |